# Trade Mark Journal No.2025/025 20 June 2025

## WO0000001845213 (5)

Office of origin: Japan

Date of International Registration:23 January 2025
Date of designation in the UK: 15 May 2025

International priority date claimed: 22 January 2025 (Japan)

Class 5
  Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for treating hematological disorders; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; pharmaceutical preparations; chemical preparations for pharmaceutical purposes; chemical reagents for medical purposes in the field of oncology.

TAIHO PHARMACEUTICAL CO., LTD.

Representative: IWASE Hitomi, Nishimura & Asahi (Gaikokuho Kyodo Jigyo),, Otemon Tower, 1-1-2 Otemachi,, Chiyoda-ku, Tokyo 100-8124, JAPAN